Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 23, 2014, 58 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $300.00 to $14,156,086.00.

Highlighted Stocks Traded by Insiders:

UDR (UDR) - FREE Research Report

Alcock Harry G, who is Senior Vice President at UDR, sold 10,000 shares at $28.02 on June 23, 2014. Following this transaction, the Senior Vice President owned 121,151 shares meaning that the stake was reduced by 7.62% with the 10,000-share transaction.

The shares most recently traded at $28.25, up $0.23, or 0.82% since the insider transaction. Historical insider transactions for UDR go as follows:

  • 4-Week # shares sold: 36,000
  • 12-Week # shares sold: 37,000
  • 24-Week # shares sold: 41,800

The average volume for UDR has been 1.5 million shares per day over the past 30 days. UDR has a market cap of $7.1 billion and is part of the financial sector and real estate industry. Shares are up 20.69% year-to-date as of the close of trading on Monday.

UDR, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It owns, operates, acquires, renovates, develops, redevelops, and manages multifamily apartment communities. The stock currently has a dividend yield of 3.68%. The company has a P/E ratio of 404.0. Currently, there are 3 analysts who rate UDR a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UDR - FREE

TheStreet Quant Ratings

rates UDR as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, revenue growth, increase in stock price during the past year and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

UDR Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Eli Lilly and (LLY) - FREE Research Report

Lilly Endowment Inc, who is 10% Owner at Eli Lilly and, sold 230,000 shares at $61.55 on June 23, 2014. Following this transaction, the 10% Owner owned 134.1 million shares meaning that the stake was reduced by 0.17% with the 230,000-share transaction.

The shares most recently traded at $62.27, up $0.72, or 1.16% since the insider transaction. Historical insider transactions for Eli Lilly and go as follows:

  • 4-Week # shares bought: 17,157
  • 4-Week # shares sold: 390,000
  • 12-Week # shares bought: 17,157
  • 12-Week # shares sold: 1.4 million
  • 24-Week # shares bought: 29,588
  • 24-Week # shares sold: 1.4 million

The average volume for Eli Lilly and has been 4.8 million shares per day over the past 30 days. Eli Lilly and has a market cap of $69.4 billion and is part of the health care sector and drugs industry. Shares are up 21.71% year-to-date as of the close of trading on Monday.

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health Products. The stock currently has a dividend yield of 3.16%. The company has a P/E ratio of 17.3. Currently, there are 5 analysts who rate Eli Lilly and a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LLY - FREE

TheStreet Quant Ratings

rates Eli Lilly and as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Eli Lilly and Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Guidewire Software (GWRE) - FREE Research Report

Blasing Karen, who is Chief Financial Officer at Guidewire Software, sold 1,914 shares at $38.91 on June 23, 2014. Following this transaction, the Chief Financial Officer owned 0 shares meaning that the stake was reduced by 100% with the 1,914-share transaction.

Hung Priscilla, who is SVP, Ops and Corp Dev at Guidewire Software, sold 5,084 shares at $38.90 on June 23, 2014. Following this transaction, the SVP, Ops and Corp Dev owned 0 shares meaning that the stake was reduced by 100% with the 5,084-share transaction.

King James Winston, who is VP, General Counsel at Guidewire Software, sold 994 shares at $38.89 on June 23, 2014. Following this transaction, the VP, General Counsel owned 0 shares meaning that the stake was reduced by 100% with the 994-share transaction.

The shares most recently traded at $40.33, up $1.44, or 3.57% since the insider transaction. Historical insider transactions for Guidewire Software go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 47,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 131,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 296,278

The average volume for Guidewire Software has been 859,400 shares per day over the past 30 days. Guidewire Software has a market cap of $2.7 billion and is part of the technology sector and computer software & services industry. Shares are down 19.75% year-to-date as of the close of trading on Monday.

Guidewire Software, Inc. provides system software to the property and casualty (P&C) insurance industry primarily in the United States, Canada, Australia, the United Kingdom, and internationally. The company has a P/E ratio of 246.1. Currently, there are 4 analysts who rate Guidewire Software a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GWRE - FREE

TheStreet Quant Ratings

rates Guidewire Software as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full

Guidewire Software Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null